Microbial Dynamics Across Commercial Spaceflights of Varying Duration
Krishnavajhala, A.; Gingras, M.-C.; Santiago-Rodriguez, T.; Chen, Y.; Bandaranaike, D.; Bhamidipati, S.; Xiang, Q.; Kottapalli, K.; Momin, Z.; Santhanam, A.; Walker, K.; Wang, Q.; Griffin, S. M.; Masternak, M. M.; Ross, M. C.; Muzny, D.; Wu, J.; Urquieta, E.; Gibbs, R.; doddapaneni, H.
Show abstract
SummarySpaceflight introduces environmental stressors that can alter human microbiomes and immune responses. We analyzed 259 biospecimens from six astronauts across two commercial ISS missions: Axiom 2 (10-day mission) and Axiom 3 (21-day mission). Samples included saliva, stool, urine, and body swabs from 10 anatomical sites, profiled via 16S ribosomal RNA (rRNA) gene sequencing. Gut and oral microbiomes remained stable, while skin-associated communities exhibited transient diversity shifts post-flight. Taxonomic analysis revealed individual and site-specific patterns as well as a possible microbial acquisition from the ISS/space-flight environment and microbiome exclusivity. Cytokine profiling from single cell data indicated immune activation, with IL-32 and IL-16 elevated in Axiom 2 and Axiom 3, coinciding with microbial changes. These findings provide an integrated view of microbiome individuality, exclusivity and immune dynamics during two short-duration commercial spaceflights of three weeks, informing strategies for crew health on future long-duration missions.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.